|Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT|
AV Gasparian, CA Burkhart, AA Purmal, L Brodsky, M Pal, M Saranadasa, ...
Science translational medicine 3 (95), 95ra74-95ra74, 2011
|FACT is a sensor of DNA torsional stress in eukaryotic cells|
A Safina, P Cheney, M Pal, L Brodsky, A Ivanov, K Kirsanov, E Lesovaya, ...
Nucleic acids research 45 (4), 1925-1945, 2017
|Blood BDNF level is gender specific in severe depression|
A Kreinin, S Lisson, E Nesher, J Schneider, J Bergman, K Farhat, J Farah, ...
PLoS One 10 (5), e0127643, 2015
|Targeting FACT complex suppresses mammary tumorigenesis in Her2/neu transgenic mice|
IE Koman, M Commane, G Paszkiewicz, B Hoonjan, S Pal, A Safina, ...
Cancer prevention research 5 (8), 1025-1035, 2012
|Apoptosis inhibitor as a suppressor of tumor progression: expression of Bcl-2 eliminates selective advantages for p53-deficient cells in the tumor|
KV Gurova, SSS Kwek, IE Koman, AP Komarov, E Kandel, MA Nikiforov, ...
Cancer biology & therapy 1 (1), 39-44, 2002
|Method for noninvasive analysis of proteins and small molecules from ancient objects|
M Manfredi, E Barberis, F Gosetti, E Conte, G Gatti, C Mattu, E Robotti, ...
Analytical chemistry 89 (6), 3310-3317, 2017
|Role of chromatin damage and chromatin trapping of FACT in mediating the anticancer cytotoxicity of DNA-binding small-molecule drugs|
E Nesher, A Safina, I Aljahdali, S Portwood, ES Wang, I Koman, J Wang, ...
Cancer research 78 (6), 1431-1443, 2018
|TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells|
K Leonova, A Safina, E Nesher, P Sandlesh, R Pratt, C Burkhart, ...
Elife 7, e30842, 2018
|Synapsin IIb as a functional marker of submissive behavior|
E Nesher, I Koman, M Gross, T Tikhonov, M Bairachnaya, ...
Scientific reports 5 (1), 1-12, 2015
|Seasonality and BDNF polymorphism influences depression outcome in patients with atopic dermatitis and psoriasis|
T Vinnik, M Kirby, M Bairachnaya, I Koman, T Tarkina, G Sadykova, ...
The World Journal of Biological Psychiatry 18 (8), 604-614, 2017
|Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19|
M Rogosnitzky, P Okediji, I Koman
Pharmacological Reports, 1-8, 2020
|Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models|
S Yacobovich, L Tuchinsky, M Kirby, T Kardash, O Agranyoni, E Nesher, ...
Oncotarget 7 (39), 63549, 2016
|Link between personality and response to THC exposure|
T Kardash, D Rodin, M Kirby, N Davis, I Koman, J Gorelick, I Michaelevski, ...
Behavioural brain research 379, 112361, 2020
|Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue|
BM Hall, AS Gleiberman, E Strom, PA Krasnov, D Frescas, S Vujcic, ...
Aging cell 19 (10), e13219, 2020
|Cytotoxicity of Exogenous Acetoacetate in Lithium Salt Form Is Mediated by Lithium and Not Acetoacetate|
R Cohen-Harazi, S Hofmann, V Kogan, H Fulman-Levy, K Abaev, ...
Anticancer Research 40 (7), 3831-3837, 2020
|Patient-derived Tumor Spheroid Cultures as a Promising Tool to Assist Personalized Therapeutic Decisions|
S Hofmann, R Cohen-Harazi, Y Maizels, I Koman
|Chromatin trapping is a key factor for anticancer cytotoxicity of DNA-binding small molecule drugs|
E Nesher, A Safina, I Aljahdali, S Portwood, E Wang, J Wang, I Koman, ...
Cancer Research 79 (13 Supplement), 1755-1755, 2019
|Personality may influence behavioral response to cannabis|
T Kardash, D Rodin, M Kirby, I Koman, I Michaelevski, A Pinhasov
BioRxiv, 674044, 2019
|Anticancer effect of a new cyclic peptide ALOS4 is associated with its systemic anti-inflammatory activity|
E Nesher, A Pinhasov, M Becker, M Kirby, RC Harazi, S Yakobovich, ...
Cancer Research 78 (13 Supplement), 2866-2866, 2018
|PO-459 Systemic anti-inflammatory effect of a new anticancer cyclic peptide ALOS4|
E Nesher, A Pinhasov, M Becker, R Cohen-Harazi, S Yakobovich, I Gitlin, ...
ESMO Open 3 (Suppl 2), 2018